COCP
Cocrystal Pharma·NASDAQ
--
--(--)
--
--(--)
5.38 / 10
Netural
Money flow is robust at 7.28/10, particularly in the Small-cap category (inflow ratio 0.553), though overall and other size bands show negative trends. Analyst sentiment is overwhelmingly bullish (100% Strong Buy from one analyst), yet the price has fallen (-5.83%) recently, indicating a mismatch between expectations and current market action.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-06-20
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for COCP?
- COCP holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.38/10 (Netural).
